trying... 28642823202204092056-992032017International journal of retina and vitreousInt J Retina VitreousVisualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography.19191910.1186/s40942-017-0074-yCentral vision loss in diabetic retinopathy is commonly related to diabetic macular edema (DME). The objective of this study was to describe changes between consecutive visits on optical coherence tomography angiography (OCTA) of the foveal avascular zone (FAZ) in eyes with DME.20 eyes from 14 patients with DME were imaged on 2 successive clinic visits separated by at least 1 month. The mean interval between visits was 3.2 months. The only intervention used was intravitreal anti-VEGF in 11 eyes; the others were observed over time without treatment. Two different readers measured FAZ area using a pseudo-automated tool in comparison to a manual tracing tool. Qualitative changes in the appearance of the vasculature surrounding the FAZ were also recorded. The retinal capillary plexus was segmented into deep and superficial plexuses, and FAZ measurements were done on the superficial, deep, and summated plexuses.Pseudo-automated and manual measurements of FAZ area decreased significantly (p < 0.05) between visits in the deep, superficial, and summated plexuses. Qualitative analysis of vasculature surrounding the FAZ showed that most of the vascular changes (65%) over time were visible in the deep plexus, compared to 30 and 20% in the superficial and summated plexuses, respectively.The most significant differences in FAZ size over time were in the summated plexus (p < 0.001), while changes in FAZ appearance were most prominent in the deep plexus. Absolute decrease in FAZ size over visits was largest in the deep plexus. Our results demonstrate that OCTA can effectively be used to measure FAZ area in patients with DME, visualize qualitative changes in retinal vasculature, and visualize the segmentation levels at which these changes can be best appreciated. However, larger studies are needed to evaluate the reproducibility of manual and pseudo-automated measuring techniques.GillAdityaANew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8ColeEmily DEDNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139 USA.0000 0001 2341 2786grid.116068.8NovaisEduardo AEANew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.0000 0001 0514 7202grid.411249.bLouzadaRicardo NRNNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8Ophthalmic Center Reference (CEROF), Federal University of Goiás, Goiânia, Brazil.0000 0001 2192 5801grid.411195.9de CarloTalisaTNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8DukerJay SJSNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8WaheedNadia KNKNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8BaumalCaroline RCRNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8WitkinAndre JAJNew England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.0000 0004 1936 7531grid.429997.8engJournal Article20170619EnglandInt J Retina Vitreous1016778972056-9920Diabetic macular edema (DME)Foveal avascular zone (FAZ)Optical coherence tomography (OCT)Optical coherence tomography angiography (OCTA)2016121420173312017624602017624602017624612017619epublish28642823PMC547485210.1186/s40942-017-0074-y74Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(11):1334–1340. doi: 10.1001/jamaophthalmol.2014.2854.10.1001/jamaophthalmol.2014.2854PMC457699425125075Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol. 2008;92(1):89–92. doi: 10.1136/bjo.2007.122416.10.1136/bjo.2007.12241617584999Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–563. doi: 10.1001/archopht.122.4.552.10.1001/archopht.122.4.55215078674Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122(7):1375–1394. doi: 10.1016/j.ophtha.2015.03.024.10.1016/j.ophtha.2015.03.02425935789Zhang X, Zeng H, Bao S, Wang N, Gillies MC. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4:27. doi: 10.1186/2045-3701-4-27.10.1186/2045-3701-4-27PMC404614224955234Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1–32. doi: 10.1016/j.survophthal.2008.10.001.10.1016/j.survophthal.2008.10.00119171208Rabbani H, Allingham MJ, Mettu PS, Cousins SW, Farsiu S. Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema. Investig Ophthalmol Vis Sci. 2015;56(3):1482–1492. doi: 10.1167/iovs.14-15457.10.1167/iovs.14-15457PMC434730925634978Salz DA, Witkin AJ. Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol. 2015;22(2):145–150. doi: 10.4103/0974-9233.151887.10.4103/0974-9233.151887PMC441160925949070de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, et al. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology. 2015;122(6):1228–1238. doi: 10.1016/j.ophtha.2015.01.029.10.1016/j.ophtha.2015.01.02925795476de Carlo TE, Salz DA, Waheed NK, Baumal CR, Duker JS, Witkin AJ. Visualization of the retinal vasculature using wide-field montage optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2015;46(6):611–616.26172062Matsunaga D, Yi J, Puliafito CA, Kashani AH. OCT angiography in healthy human subjects. Ophthalmic Surg Lasers Imaging Retina. 2014;45(6):510–515. doi: 10.3928/23258160-20141118-04.10.3928/23258160-20141118-0425423629Conrath J, Giorgi R, Raccah D, Ridings B. Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye. 2005;19(3):322–326. doi: 10.1038/sj.eye.6701456.10.1038/sj.eye.670145615258601Weerasekera LY, Balmer LA, Ram R, Morahan G. Characterization of retinal vascular and neural damage in a novel model of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2015;56(6):3721–3730. doi: 10.1167/iovs.14-16289.10.1167/iovs.14-1628926047174Weinhaus RS, Burke JM, Delori FC, Snodderly DM. Comparison of fluorescein angiography with microvascular anatomy of macaque retinas. Exp Eye Res. 1995;61(1):1–16. doi: 10.1016/S0014-4835(95)80053-0.10.1016/S0014-4835(95)80053-07556462Yu S, Lu J, Cao D, Liu R, Liu B, Li T, et al. The role of optical coherence tomography angiography in fundus vascular abnormalities. BMC Ophthalmol. 2016;16:107. doi: 10.1186/s12886-016-0277-2.10.1186/s12886-016-0277-2PMC494442927412442Magrath GN, Say EA, Sioufi K, Ferenczy S, Samara WA, Shields CL. Variability in foveal avascular zone and capillary density using optical coherence tomography angiography machines in healthy eyes. Retina. 201627997512Samara WA, Say EA, Khoo CT, Higgins TP, Magrath G, Ferenczy S, et al. Correlation of foveal avascular zone size with foveal morphology in normal eyes using optical coherence tomography angiography. Retina. 2015;35(11):2188–2195. doi: 10.1097/IAE.0000000000000847.10.1097/IAE.000000000000084726469536Carpineto P, Mastropasqua R, Marchini G, Toto L, Di Nicola M, Di Antonio L. Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography. Br J Ophthalmol. 2016;100(5):671–676. doi: 10.1136/bjophthalmol-2015-307330.10.1136/bjophthalmol-2015-30733026377414Mendis KR, Balaratnasingam C, Yu P, Barry CJ, McAllister IL, Cringle SJ, et al. Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail. Investig Ophthalmol Vis Sci. 2010;51(11):5864–5869. doi: 10.1167/iovs.10-5333.10.1167/iovs.10-533320505200Di G, Weihong Y, Xiao Z, Zhikun Y, Xuan Z, Yi Q, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefe’s Arch Clin Exp Ophthalmol. 201526344729Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S. Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2015PMC488457026338819Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377–2383. doi: 10.1097/IAE.0000000000000849.10.1097/IAE.000000000000084926457396Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(8):3907–3913. doi: 10.1167/iovs.16-19570.10.1167/iovs.16-1957027472076Coscas F, Sellam A, Glacet-Bernard A, Jung C, Goudot M, Miere A, et al. Normative data for vascular density in superficial and deep capillary plexuses of healthy adults assessed by optical coherence tomography angiography. Investig Ophthalmol Vis Sci. 201627409475Fogli S, Mogavero S, Egan CG, Del Re M, Danesi R. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema. Pharmacol Res. 201526607863Miwa Y, Murakami T, Suzuma K, Uji A, Yoshitake S, Fujimoto M, et al. Relationship between functional and structural changes in diabetic vessels in optical coherence tomography angiography. Sci Rep. 2016;6:29064. doi: 10.1038/srep29064.10.1038/srep29064PMC492414227350562Tam J, Dhamdhere KP, Tiruveedhula P, Lujan BJ, Johnson RN, Bearse MA, Jr, et al. Subclinical capillary changes in non-proliferative diabetic retinopathy. Optom Vis Sci. 2012;89(5):E692–E703. doi: 10.1097/OPX.0b013e3182548b07.10.1097/OPX.0b013e3182548b07PMC334837422525131Nelson DA, Burgansky-Eliash Z, Barash H, Loewenstein A, Barak A, Bartov E, et al. High-resolution wide-field imaging of perfused capillaries without the use of contrast agent. Clin Ophthalmol. 2011;5:1095–1106.PMC316228621887088Matsunaga DR, Yi JJ, De Koo LO, Ameri H, Puliafito CA, Kashani AH. Optical coherence tomography angiography of diabetic retinopathy in human subjects. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):796–805. doi: 10.3928/23258160-20150909-03.10.3928/23258160-20150909-0326431294trying2... trying... trying2...
Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography. | LitMetric
New England Eye Center, Tufts Medical Center, Tufts University, 800 Washington Street, Box 450, Boston, MA 02111 USA.
Published: June 2017
Background: Central vision loss in diabetic retinopathy is commonly related to diabetic macular edema (DME). The objective of this study was to describe changes between consecutive visits on optical coherence tomography angiography (OCTA) of the foveal avascular zone (FAZ) in eyes with DME.
Methods: 20 eyes from 14 patients with DME were imaged on 2 successive clinic visits separated by at least 1 month. The mean interval between visits was 3.2 months. The only intervention used was intravitreal anti-VEGF in 11 eyes; the others were observed over time without treatment. Two different readers measured FAZ area using a pseudo-automated tool in comparison to a manual tracing tool. Qualitative changes in the appearance of the vasculature surrounding the FAZ were also recorded. The retinal capillary plexus was segmented into deep and superficial plexuses, and FAZ measurements were done on the superficial, deep, and summated plexuses.
Results: Pseudo-automated and manual measurements of FAZ area decreased significantly ( < 0.05) between visits in the deep, superficial, and summated plexuses. Qualitative analysis of vasculature surrounding the FAZ showed that most of the vascular changes (65%) over time were visible in the deep plexus, compared to 30 and 20% in the superficial and summated plexuses, respectively.
Conclusions: The most significant differences in FAZ size over time were in the summated plexus ( < 0.001), while changes in FAZ appearance were most prominent in the deep plexus. Absolute decrease in FAZ size over visits was largest in the deep plexus. Our results demonstrate that OCTA can effectively be used to measure FAZ area in patients with DME, visualize qualitative changes in retinal vasculature, and visualize the segmentation levels at which these changes can be best appreciated. However, larger studies are needed to evaluate the reproducibility of manual and pseudo-automated measuring techniques.